Description
Analysing novel vaccine design and delivery methods in order to translate evidence into clinical success
Following our series of successful marcus evans DNA Vaccines conferences much progress has been made with the successful approval of DNA vaccines for veterinary use, which has brought renewed expectations in this field.
Further developments in electroporation and other novel delivery methods have changed the vaccines landscape. Therefore, this year we will be evaluating the newly developed delivery techniques and how to overcome the challenges faced. The conference will also profile the clinical developments in different diseases areas with the latest clinical data, how prime boost strategies are advancing and analyse the funding opportunities available for small biotechs in the current climate to ensure survival.
